Component

Urinary recovery of orally administered vanadium

Context-specific entity; species, compartment and exposure are stated on each claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. Daily urinary recovery was roughly 1% or less of administered elemental V in the trial, used by the authors to estimate low oral absorption.

    Experimental context and source evidence
    evidence_access
    Primary full text
    experimental_model
    Same cohort; steady-state urine measurements.
    limitations
    The full text calls this a minimum absorption estimate because tissue accumulation and other compartments can matter; do not present it as complete mass balance.
    nutrient_topic
    Vanadium collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Vanadium
    plain_language
    Only a small fraction of the oral dose appeared in urine each day.
    primary_references
    Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23982218/ · DOI 10.1039/c3mt00162h

    Vanadium: speciation, phosphate-sensitive enzymes and cross-nutrient mechanisms (2026-09-19) · lines 430–436

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Same cohort; steady-state urine measurements. · source_derived_draft · unverified_draft

    ## vanadium-human-absorption-estimate Only a small fraction of the oral dose appeared in urine each day. Daily urinary recovery was roughly 1% or less of administered elemental V in the trial, used by the authors to estimate low oral absorption. Model: Same cohort; steady-state urine measurements. Limitations: The full text calls this a minimum absorption estimate because tissue accumulation and other compartments can matter; do not present it as complete mass balance. Evidence access: Primary full text Coordination chemistry may explain pharmacokinetics and clinical response of vanadyl sulfate in type 2 diabetic patients. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23982218/ · DOI 10.1039/c3mt00162h
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards